Successful treatment with nab-paclitaxel after hypersensitivity reaction to paclitaxel and docetaxel.

Autor:	de Leon MC; Indiana University, Gynecologic Oncology Division, 535 Barnhill Drive, Rm 435, Indianapolis, IN 46202, USA., Bolla S; American Health Network Hematology Oncology, 1111 Ronald Reagan Pkwy #B1500, Avon, IN 46123, USA., Greene B; Indiana University, Gynecologic Oncology Division, 535 Barnhill Drive, Rm 435, Indianapolis, IN 46202, USA., Hutchinson L; Indiana University, Gynecologic Oncology Division, 535 Barnhill Drive, Rm 435, Indianapolis, IN 46202, USA., Del Priore G; Indiana University, Gynecologic Oncology Division, 535 Barnhill Drive, Rm 435, Indianapolis, IN 46202, USA.
Jazyk:	angličtina
Zdroj:	Gynecologic oncology case reports [Gynecol Oncol Case Rep] 2013 May 14; Vol. 5, pp. 70-1. Date of Electronic Publication: 2013 May 14 (Print Publication: 2013).
DOI:	10.1016/j.gynor.2013.05.003
Abstrakt:	•First case report of successfully treating severe paclitaxel and docetaxel hypersensitivity reaction with nab-paclitaxel•We demonstrated that nab-paclitaxel is a safe taxane chemotherapy treatment option for patients who could not tolerate paclitaxel or docetaxel.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu